Masmudur M Rahman Selected Research

Masmudur M Rahman Research Topics

Disease

26	Neoplasms (Cancer) 08/2022 - 09/2009
13	Infections 01/2022 - 10/2009
6	Virus Diseases (Viral Diseases) 01/2021 - 10/2009
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 04/2010
4	Vaccinia 01/2013 - 05/2007
3	Smallpox (Variola) 01/2021 - 06/2009
3	Ovarian Neoplasms (Ovarian Cancer) 12/2020 - 05/2012
3	Glioma (Gliomas) 01/2016 - 01/2010
2	Multiple Myeloma 01/2022 - 09/2020
2	Residual Neoplasm 09/2020 - 03/2017
1	Reinfection 08/2022
1	Adenocarcinoma 04/2022
1	Osteosarcoma (Osteogenic Sarcoma) 09/2021
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Rupture 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Melanoma (Melanoma, Malignant) 09/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Neuroendocrine Carcinoma 01/2019
1	Embryonal Rhabdomyosarcoma 12/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2016
1	Hematologic Diseases (Blood Diseases) 03/2016
1	Lymphoma (Lymphomas) 07/2015
1	Uveitis 01/2015
1	Inflammation (Inflammations) 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 07/2013
1	Brain Neoplasms (Brain Tumor) 07/2013
1	Ascites 05/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012
1	Autoimmune Diseases (Autoimmune Disease) 08/2011
1	Necrosis 09/2009

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2007
5	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2009
5	CytokinesIBA 12/2011 - 09/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 08/2011
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 07/2013 - 01/2010
2	Gemcitabine FDA Link 04/2022 - 04/2012
2	VaccinesIBA 01/2021 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2007
2	RNA Helicases (RNA Helicase)IBA 01/2021 - 11/2017
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 04/2016
2	AntigensIBA 01/2020 - 03/2016
2	Small Interfering RNA (siRNA)IBA 11/2017 - 12/2011
2	Temozolomide (Temodar)FDA LinkGeneric 01/2016 - 07/2013
2	Interleukin-6 (Interleukin 6)IBA 09/2014 - 12/2011
2	ChemokinesIBA 12/2011 - 10/2009
2	InflammasomesIBA 12/2011 - 10/2009
1	Praziquantel (Biltricide)FDA Link 08/2022
1	LCL161IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	LuciferasesIBA 03/2021
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2020
1	InterleukinsIBA 09/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018
1	DEAD-box RNA HelicasesIBA 11/2017
1	Protein SIBA 01/2017
1	EndotoxinsIBA 01/2015
1	Green Fluorescent ProteinsIBA 01/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2013
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2012
1	SuspensionsIBA 05/2012
1	resazurinIBA 05/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2011
1	Mitogen-Activated Protein KinasesIBA 12/2011
1	Z-Form DNA (Z-DNA)IBA 10/2011
1	Virulence Factors (Pathogenicity Factors)IBA 10/2011
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	GenisteinIBA 06/2010
1	Tyrosine Kinase InhibitorsIBA 06/2010
1	NF-KappaB Inhibitor alphaIBA 10/2009
1	interleukin-1beta-converting enzyme inhibitorIBA 10/2009
1	NF-kappa B (NF-kB)IBA 10/2009
1	Viral ProteinsIBA 09/2009
1	InterferonsIBA 09/2009
1	Viral DNAIBA 05/2007
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2007

Therapy/Procedure

14	Therapeutics 08/2022 - 04/2010
10	Oncolytic Virotherapy 01/2021 - 01/2012
4	Immunotherapy 01/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 09/2021 - 04/2010
1	Stem Cell Transplantation 01/2022
1	Radiotherapy 09/2021
1	Autologous Transplantation 09/2020
1	Hematopoietic Stem Cell Transplantation 03/2016
1	Cell Transplantation 03/2016
1	Heterologous Transplantation (Xenotransplantation) 07/2015
1	Intravitreal Injections 01/2015
1	Transplantation 04/2010